Furthermore, it is assumed that there is a potential relationship between diminished IGF-1 levels and neurodegenerative diseases [73,80,81], which suggests that influencing IGF-1 levels is a promising target for efficient treatments. Here, IGF1 is linked to neurodegenerative disease.